March 2020 | Volume 1
Disparities in healthcare (related to geography, race, gender, and socio-economic status) aren't just prevalent in access and delivery of care. Our very systems of research — from clinical trials to outcomes research — overlook diverse communities. We see the results of this disparity in the epidemic of chronic illness and substance use, the inability to understand how to best use our resources to achieve health and wellness and the perpetuation of care that is neither accessible nor affordable to all. I’m reading more lately about the need to stare these inequities down and to identify solutions for greater inclusion and engagement. It’s a challenge that we’re long overdue in tackling.
Drop in cancer deaths reflect failures of our society. Really
Last year we learned that the number of people dying from cancer in 2017 was 2 percent lower than expected. Just about everyone’s guess was that a raft of remarkable new cancer treatments, $150,000 per year, was the reason.
Costs, Benefits, and Sacred Values — Why Health Care Reform Is So Fraught
As debate about U.S health care begins anew, with particular focus on a “Medicare for All” type insurance design, it’s worth considering why weighing the complex but real trade-offs involved in health policy remains so politically challenging.
Population-Based Payments May Help Ensure Access To Life-Saving Antibiotics For Medicare Beneficiaries
In 2019, the Centers for Disease Control and Prevention (CDC) released an updated report on Antibiotic Resistance Threats in the United States, which includes a list of pathogen threats categorized as urgent, serious, and concerning. The new numbers are sobering: Nearly three million Americans contract antibiotic-resistant infections every year, and more than 35,000 people die as a result.
Effect of Adding a Work-Focused Intervention to Integrated Care for Depression in the Veterans Health Administration
Is a telephonic work-focused counselling program combined with the Veterans Health Administration’s mental health integrated care (IC) program superior to IC alone for improving the occupational functioning and depression symptom severity of employed veterans with depression and work limitations?
Disparities in Clinical Trial Access Across US Urban Areas
A lack of geographically convenient clinical trial sites hinders study participation, particularly for rural residents. But even in more densely populated regions, where most US residents live, trial locations may not be optimized to maximize access. In this cross-sectional study, we explored whether availability of trial seats in nonrural regions varies with population, racial and socioeconomic compositions, research activity, or amount of health care infrastructure.
How Can We Dismantle Health Equity Barriers In Research?
Research funders must be vigilant in working purposefully toward health equity. As a community, we must examine biases that may be hidden in our processes and may be promoting inequities inadvertently. There are many possible reasons, including health inequities in data systems that are used in research; the research topics that are solicited; and potential bias in evaluating grant proposals.
Closing The Medicaid Coverage Gap: Options For Reform
Eight years after the US Supreme Court’s landmark decision in National Federation of Independent Business v. Sebelius, more than two million of the nation’s poorest working-age adults continue to feel its effects. These are the people who, because of the decision, remain without a pathway to affordable health insurance coverage because they live in a state that has not expanded Medicaid under the Affordable Care Act (ACA).
Can We Measure Caregiver Burden and Other Indirect Benefits in Value Assessments?
What prevents consideration of broader individual and societal benefits when assessing the value of innovative medical treatments and making health care coverage determinations? In new research published in the Journal of Occupational and Environmental Medicine, researchers at NPC and RTI Health Solutions surveyed health insurance providers, pharmacy benefit managers, employee benefit consultants and employer groups  to identify barriers and solutions  to evaluating four indirect treatment benefits: absenteeism, presenteeism, caregiver burden, and quality of life .
Tech, empowered patients changing rare-disease paradigm
A vast number of people have a disease that relatively few others have, making rare diseases quite common, writes geneticist Claire Novorol, cofounder of Ada Health. A lack of robust data, too little funding and too few patients for clinical trials stand in the way of cures, but artificial intelligence, new epidemiological and clinical trial methods, genetic testing and genome sequencing, and tools that empower patients are changing the paradigm, Novorol writes.

Passion + Quality = Change That Matters
I embrace the powerful opportunities in our evolving health care landscape. I founded Momentum Health Strategies to be a catalyst for change through continuous learning, diverse engagement and thoughtful policy and practice initiatives. I deliver innovative, strategic thinking and a passion for improving the patient experience. My personal drive and dedication to high-quality results will help you navigate the competitive terrain you face and convert your vision to action.

Momentum Health Strategies

Jennifer L Bright, MPA
(703) 628 - 0534